
Why Is Philippe Laffont Buying TSM?
With a personal net worth of approximately $6.5 billion and…
Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
---|---|---|---|---|---|
OSCR
Oscar Health
|
$2.5B | -$0.58 | 32.34% | 45.16% | $19.93 |
ALHC
Alignment Healthcare
|
$677.4M | -$0.08 | 44.37% | -56% | $14.00 |
CI
The Cigna Group
|
$63.2B | $7.82 | 8.83% | 124.09% | $362.31 |
CLOV
Clover Health Investments
|
$347.4M | -$0.07 | 14.6% | -55.58% | $4.80 |
ELV
Elevance Health
|
$44.7B | $3.85 | 8.76% | 10.87% | $494.29 |
UNH
UnitedHealth Group
|
$101.7B | $6.74 | 11.86% | 15.56% | $637.24 |
Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
---|---|---|---|---|---|---|---|
OSCR
Oscar Health
|
$14.82 | $19.93 | $3.7B | -- | $0.00 | 0% | 0.44x |
ALHC
Alignment Healthcare
|
$13.18 | $14.00 | $2.5B | -- | $0.00 | 0% | 1.01x |
CI
The Cigna Group
|
$299.81 | $362.31 | $82.1B | 24.49x | $1.40 | 1.87% | 0.35x |
CLOV
Clover Health Investments
|
$4.40 | $4.80 | $2.2B | -- | $0.00 | 0% | 1.06x |
ELV
Elevance Health
|
$385.10 | $494.29 | $87.6B | 15.04x | $1.63 | 1.69% | 0.51x |
UNH
UnitedHealth Group
|
$466.42 | $637.24 | $429.2B | 30.09x | $2.10 | 1.75% | 1.08x |
Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
---|---|---|---|---|
OSCR
Oscar Health
|
22.81% | 1.729 | 8.89% | 0.96x |
ALHC
Alignment Healthcare
|
64.92% | 1.330 | 9.36% | 1.45x |
CI
The Cigna Group
|
43.8% | 1.702 | -- | 0.80x |
CLOV
Clover Health Investments
|
-- | 1.635 | -- | 1.45x |
ELV
Elevance Health
|
43.05% | 1.124 | 37.17% | 2.01x |
UNH
UnitedHealth Group
|
43.9% | 1.199 | 16.37% | 0.50x |
Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
---|---|---|---|---|---|---|
OSCR
Oscar Health
|
-- | -- | 1.91% | 2.46% | -6.17% | $340M |
ALHC
Alignment Healthcare
|
$79M | -$19.5M | -44.24% | -100.09% | -2.82% | $16.9M |
CI
The Cigna Group
|
-- | -- | 4.58% | 6.99% | 2.5% | -$353M |
CLOV
Clover Health Investments
|
$81.2M | -$9.3M | -29.15% | -29.15% | -2.65% | $49.6M |
ELV
Elevance Health
|
-- | -- | 8.66% | 14.4% | 2.08% | $384M |
UNH
UnitedHealth Group
|
$21.3B | $7.8B | 8.3% | 14.34% | 7.73% | $1.5B |
Alignment Healthcare has a net margin of -6.42% compared to Oscar Health's net margin of -3.82%. Oscar Health's return on equity of 2.46% beat Alignment Healthcare's return on equity of -100.09%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
OSCR
Oscar Health
|
-- | -$0.62 | $1.3B |
ALHC
Alignment Healthcare
|
11.41% | -$0.14 | $327.6M |
Oscar Health has a consensus price target of $19.93, signalling upside risk potential of 34.47%. On the other hand Alignment Healthcare has an analysts' consensus of $14.00 which suggests that it could grow by 6.22%. Given that Oscar Health has higher upside potential than Alignment Healthcare, analysts believe Oscar Health is more attractive than Alignment Healthcare.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
OSCR
Oscar Health
|
2 | 1 | 1 |
ALHC
Alignment Healthcare
|
8 | 3 | 0 |
Oscar Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Alignment Healthcare has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
Oscar Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alignment Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Oscar Health pays -- of its earnings as a dividend. Alignment Healthcare pays out -- of its earnings as a dividend.
Oscar Health quarterly revenues are $2.4B, which are larger than Alignment Healthcare quarterly revenues of $692.4M. Oscar Health's net income of -$153.5M is lower than Alignment Healthcare's net income of -$26.4M. Notably, Oscar Health's price-to-earnings ratio is -- while Alignment Healthcare's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health is 0.44x versus 1.01x for Alignment Healthcare. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
OSCR
Oscar Health
|
0.44x | -- | $2.4B | -$153.5M |
ALHC
Alignment Healthcare
|
1.01x | -- | $692.4M | -$26.4M |
The Cigna Group has a net margin of -6.42% compared to Oscar Health's net margin of 2.17%. Oscar Health's return on equity of 2.46% beat The Cigna Group's return on equity of 6.99%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
OSCR
Oscar Health
|
-- | -$0.62 | $1.3B |
CI
The Cigna Group
|
-- | $5.13 | $75.1B |
Oscar Health has a consensus price target of $19.93, signalling upside risk potential of 34.47%. On the other hand The Cigna Group has an analysts' consensus of $362.31 which suggests that it could grow by 21.33%. Given that Oscar Health has higher upside potential than The Cigna Group, analysts believe Oscar Health is more attractive than The Cigna Group.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
OSCR
Oscar Health
|
2 | 1 | 1 |
CI
The Cigna Group
|
13 | 5 | 0 |
Oscar Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Cigna Group has a beta of 0.541, suggesting its less volatile than the S&P 500 by 45.852%.
Oscar Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Cigna Group offers a yield of 1.87% to investors and pays a quarterly dividend of $1.40 per share. Oscar Health pays -- of its earnings as a dividend. The Cigna Group pays out -- of its earnings as a dividend.
Oscar Health quarterly revenues are $2.4B, which are smaller than The Cigna Group quarterly revenues of $65.6B. Oscar Health's net income of -$153.5M is lower than The Cigna Group's net income of $1.4B. Notably, Oscar Health's price-to-earnings ratio is -- while The Cigna Group's PE ratio is 24.49x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health is 0.44x versus 0.35x for The Cigna Group. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
OSCR
Oscar Health
|
0.44x | -- | $2.4B | -$153.5M |
CI
The Cigna Group
|
0.35x | 24.49x | $65.6B | $1.4B |
Clover Health Investments has a net margin of -6.42% compared to Oscar Health's net margin of -2.77%. Oscar Health's return on equity of 2.46% beat Clover Health Investments's return on equity of -29.15%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
OSCR
Oscar Health
|
-- | -$0.62 | $1.3B |
CLOV
Clover Health Investments
|
24.54% | -$0.02 | $342.2M |
Oscar Health has a consensus price target of $19.93, signalling upside risk potential of 34.47%. On the other hand Clover Health Investments has an analysts' consensus of $4.80 which suggests that it could grow by 6.25%. Given that Oscar Health has higher upside potential than Clover Health Investments, analysts believe Oscar Health is more attractive than Clover Health Investments.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
OSCR
Oscar Health
|
2 | 1 | 1 |
CLOV
Clover Health Investments
|
2 | 2 | 0 |
Oscar Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Clover Health Investments has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
Oscar Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Clover Health Investments offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Oscar Health pays -- of its earnings as a dividend. Clover Health Investments pays out -- of its earnings as a dividend.
Oscar Health quarterly revenues are $2.4B, which are larger than Clover Health Investments quarterly revenues of $331M. Oscar Health's net income of -$153.5M is lower than Clover Health Investments's net income of -$9.2M. Notably, Oscar Health's price-to-earnings ratio is -- while Clover Health Investments's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health is 0.44x versus 1.06x for Clover Health Investments. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
OSCR
Oscar Health
|
0.44x | -- | $2.4B | -$153.5M |
CLOV
Clover Health Investments
|
1.06x | -- | $331M | -$9.2M |
Elevance Health has a net margin of -6.42% compared to Oscar Health's net margin of 0.92%. Oscar Health's return on equity of 2.46% beat Elevance Health's return on equity of 14.4%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
OSCR
Oscar Health
|
-- | -$0.62 | $1.3B |
ELV
Elevance Health
|
-- | $1.81 | $72.7B |
Oscar Health has a consensus price target of $19.93, signalling upside risk potential of 34.47%. On the other hand Elevance Health has an analysts' consensus of $494.29 which suggests that it could grow by 28.35%. Given that Oscar Health has higher upside potential than Elevance Health, analysts believe Oscar Health is more attractive than Elevance Health.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
OSCR
Oscar Health
|
2 | 1 | 1 |
ELV
Elevance Health
|
12 | 5 | 0 |
Oscar Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.835, suggesting its less volatile than the S&P 500 by 16.48%.
Oscar Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elevance Health offers a yield of 1.69% to investors and pays a quarterly dividend of $1.63 per share. Oscar Health pays -- of its earnings as a dividend. Elevance Health pays out 25.22% of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Oscar Health quarterly revenues are $2.4B, which are smaller than Elevance Health quarterly revenues of $45.4B. Oscar Health's net income of -$153.5M is lower than Elevance Health's net income of $418M. Notably, Oscar Health's price-to-earnings ratio is -- while Elevance Health's PE ratio is 15.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health is 0.44x versus 0.51x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
OSCR
Oscar Health
|
0.44x | -- | $2.4B | -$153.5M |
ELV
Elevance Health
|
0.51x | 15.04x | $45.4B | $418M |
UnitedHealth Group has a net margin of -6.42% compared to Oscar Health's net margin of 5.5%. Oscar Health's return on equity of 2.46% beat UnitedHealth Group's return on equity of 14.34%.
Company | Gross Margin | Earnings Per Share | Invested Capital |
---|---|---|---|
OSCR
Oscar Health
|
-- | -$0.62 | $1.3B |
UNH
UnitedHealth Group
|
21.14% | $5.98 | $179.5B |
Oscar Health has a consensus price target of $19.93, signalling upside risk potential of 34.47%. On the other hand UnitedHealth Group has an analysts' consensus of $637.24 which suggests that it could grow by 36.62%. Given that UnitedHealth Group has higher upside potential than Oscar Health, analysts believe UnitedHealth Group is more attractive than Oscar Health.
Company | Buy Ratings | Hold Ratings | Sell Ratings |
---|---|---|---|
OSCR
Oscar Health
|
2 | 1 | 1 |
UNH
UnitedHealth Group
|
20 | 1 | 0 |
Oscar Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.615, suggesting its less volatile than the S&P 500 by 38.534%.
Oscar Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group offers a yield of 1.75% to investors and pays a quarterly dividend of $2.10 per share. Oscar Health pays -- of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Oscar Health quarterly revenues are $2.4B, which are smaller than UnitedHealth Group quarterly revenues of $100.8B. Oscar Health's net income of -$153.5M is lower than UnitedHealth Group's net income of $5.5B. Notably, Oscar Health's price-to-earnings ratio is -- while UnitedHealth Group's PE ratio is 30.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Oscar Health is 0.44x versus 1.08x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.
Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
---|---|---|---|---|
OSCR
Oscar Health
|
0.44x | -- | $2.4B | -$153.5M |
UNH
UnitedHealth Group
|
1.08x | 30.09x | $100.8B | $5.5B |
Signup to receive the latest stock alerts
With a personal net worth of approximately $6.5 billion and…
The degree to which the healthcare paradigm has changed is…
While the world focuses on AI, the leaders over at…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.3T
P/E Ratio: 113x
Market Cap: $3T
P/E Ratio: 35x
Globant SA [GLOB] is up 2.83% over the past day.
Hims & Hers Health [HIMS] is down 19.28% over the past day.
Vicor [VICR] is down 5.16% over the past day.